Regulatory tracker: FDA delays decision on Amgen's Lumakras, Vectibix combo in metastatic colorectal cancer
Welcome to Fierce Pharma's regulatory tracker for the second half of 2024. On this page, we're recording the regulatory progress of in-market products, including expansions into key geographies and new indications. UPDATED: Friday, Oct. 18 at 8:50 …